Merck & Co. Inc.

MRK | NYSE

Price Alert Chart Builder DCF Calculator

$148.91

+$2.04 (+1.39%)

Sep 21, 2026, 12:50 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	64.93B	64.17B	60.12B	59.28B	48.7B	41.52B
Cost of Revenue	18.2B	15.19B	16.13B	17.41B	13.63B	13.62B
Gross Profit	46.73B	48.98B	43.99B	41.87B	35.08B	27.9B
Operating Income	23.49B	20.22B	2.95B	18.28B	13.2B	5.55B
Interest Income	343M	415M	365M	157M	36M	59M
Pretax Income	21.07B	19.94B	1.89B	16.44B	13.88B	5.86B
Net Income	18.25B	17.12B	365M	14.52B	13.05B	7.07B
Selling & General & Admin	10.73B	10.1B	9.88B	9.67B	9.4B	8.57B
Research & Development	12.51B	17.94B	30.53B	13.55B	12.25B	13.4B
Other Expenses	n/a	716M	620M	373M	231M	386M
Operating Expenses	23.25B	28.75B	41.04B	23.59B	21.88B	22.35B
Interest Expense	1.36B	1.27B	1.15B	962M	806M	831M
Selling & Marketing Expenses	n/a	2.4B	2.3B	2.2B	2B	1.8B
Cost & Expenses	41.44B	43.95B	57.16B	41B	35.51B	35.97B
Income Tax Expense	2.8B	2.8B	1.51B	1.92B	1.52B	1.34B
Shares Outstanding (Basic)	2.5B	2.53B	2.61B	2.53B	2.53B	2.53B
Shares Outstanding (Diluted)	2.51B	2.54B	2.55B	2.54B	2.54B	2.54B
EPS (Basic)	7.30	6.76	0.14	5.73	5.16	2.79
EPS (Diluted)	7.28	6.74	0.14	5.71	5.14	2.78
EBITDA	28.26B	25.71B	6.91B	21.32B	17.9B	10.18B
EBIT	22.42B	21.21B	3.04B	17.41B	14.69B	6.69B
Depreciation & Amortization	5.84B	4.5B	3.87B	3.91B	3.21B	3.49B